Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Parkinson's Disease

  Free Subscription


13.03.2017

2 Drugs
1 Exp Brain Res
1 J Neural Transm (Vienna)
6 Mov Disord
1 Nat Rev Neurol
1 PLoS Biol
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Drugs

  1. VIJAYAKUMAR D, Jankovic J
    Drug-Induced Dyskinesia, Part 1: Treatment of Levodopa-Induced Dyskinesia.
    Drugs. 2016;76:759-77.
    PubMed     Text format     Abstract available

  2. VIJAYAKUMAR D, Jankovic J
    Drug-Induced Dyskinesia, Part 2: Treatment of Tardive Dyskinesia.
    Drugs. 2016;76:779-87.
    PubMed     Text format     Abstract available


    Exp Brain Res

  3. FUKUSHIMA K, Fukushima J, Barnes GR
    Clinical application of eye movement tasks as an aid to understanding Parkinson's disease pathophysiology.
    Exp Brain Res. 2017 Mar 3. doi: 10.1007/s00221-017-4916.
    PubMed     Text format     Abstract available


    J Neural Transm (Vienna)

  4. SYRIMI ZJ, Vojtisek L, Eliasova I, Viskova J, et al
    Arterial spin labelling detects posterior cortical hypoperfusion in non-demented patients with Parkinson's disease.
    J Neural Transm (Vienna). 2017 Mar 7. doi: 10.1007/s00702-017-1703.
    PubMed     Text format     Abstract available


    Mov Disord

  5. HANSEN AK, Damholdt MF, Fedorova TD, Knudsen K, et al
    In Vivo cortical tau in Parkinson's disease using 18F-AV-1451 positron emission tomography.
    Mov Disord. 2017 Mar 3. doi: 10.1002/mds.26961.
    PubMed     Text format     Abstract available

  6. PEREZ XA, Zhang D, Bordia T, Quik M, et al
    Striatal D1 medium spiny neuron activation induces dyskinesias in parkinsonian mice.
    Mov Disord. 2017 Mar 3. doi: 10.1002/mds.26955.
    PubMed     Text format     Abstract available

  7. PAGANO G, Niccolini F, Yousaf T, Wilson H, et al
    Urinary dysfunction in early de novo patients with Parkinson's disease.
    Mov Disord. 2017 Mar 3. doi: 10.1002/mds.26967.
    PubMed     Text format    

  8. ANDERKOVA L, Barton M, Rektorova I
    Striato-cortical connections in Parkinson's and Alzheimer's diseases: Relation to cognition.
    Mov Disord. 2017 Mar 3. doi: 10.1002/mds.26956.
    PubMed     Text format     Abstract available

  9. F HERNANDEZ L, Castela I, Ruiz-DeDiego I, Obeso JA, et al
    Striatal activation by optogenetics induces dyskinesias in the 6-hydroxydopamine rat model of Parkinson disease.
    Mov Disord. 2017 Mar 3. doi: 10.1002/mds.26947.
    PubMed     Text format     Abstract available

  10. MEROLA A, Romagnolo A, Comi C, Rosso M, et al
    Prevalence and burden of dysautonomia in advanced Parkinson's disease.
    Mov Disord. 2017 Mar 3. doi: 10.1002/mds.26970.
    PubMed     Text format    


    Nat Rev Neurol

  11. AARSLAND D, Creese B, Politis M, Chaudhuri KR, et al
    Cognitive decline in Parkinson disease.
    Nat Rev Neurol. 2017 Mar 3. doi: 10.1038/nrneurol.2017.
    PubMed     Text format     Abstract available


    PLoS Biol

  12. DE OLIVEIRA RM, Vicente Miranda H, Francelle L, Pinho R, et al
    The mechanism of sirtuin 2-mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease.
    PLoS Biol. 2017;15:e2000374.
    PubMed     Text format     Abstract available


    PLoS One

  13. WENG CC, Chen ZA, Chao KT, Ee TW, et al
    Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson's disease using in vivo 18F-9-fluoropropyl-(+)-dihydrotetrabenazine PET imaging.
    PLoS One. 2017;12:e0173503.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: